UA115520C2 - Дієтична або фармацевтична композиція на основі лактобацил для вагінального або перорального введення - Google Patents

Дієтична або фармацевтична композиція на основі лактобацил для вагінального або перорального введення

Info

Publication number
UA115520C2
UA115520C2 UAA201302550A UAA201302550A UA115520C2 UA 115520 C2 UA115520 C2 UA 115520C2 UA A201302550 A UAA201302550 A UA A201302550A UA A201302550 A UAA201302550 A UA A201302550A UA 115520 C2 UA115520 C2 UA 115520C2
Authority
UA
Ukraine
Prior art keywords
vaginal
compositions
lactobacillus
oral administration
physiologic
Prior art date
Application number
UAA201302550A
Other languages
English (en)
Inventor
Герберт Кісс
Вольфґанґ Кніфель
Конрад Дж. Доміґ
Френк М. Унґер
Гельмут Вернштейн
Original Assignee
Гсо Гелс Кеа Ґмбг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43798526&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA115520(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Гсо Гелс Кеа Ґмбг filed Critical Гсо Гелс Кеа Ґмбг
Publication of UA115520C2 publication Critical patent/UA115520C2/uk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/38—Other non-alcoholic beverages
    • A23L2/382—Other non-alcoholic beverages fermented
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/145—Gasseri
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/149—Jensenii
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/175—Rhamnosus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Nutrition Science (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Reproductive Health (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Винахід стосується дієтичної або фармацевтичної композиції, що містить комбінацію принаймні чотирьох автохтонних відносно до людини штамів Lactobacillus crispatus DSM 22566, Lactobacillus rhamnosus DSM 22560, Lactobacillus jensenii DSM 22567, Lactobacillus gasseri DSM 22583 для перорального та вагінального введення; комбінації вказаних штамів та продукту, що містить вказані композиції.
UAA201302550A 2010-09-14 2011-09-13 Дієтична або фармацевтична композиція на основі лактобацил для вагінального або перорального введення UA115520C2 (uk)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10176578A EP2428214A1 (en) 2010-09-14 2010-09-14 Compositions for the vaginal and oral administration of lactobacillus and uses thereof
US41296410P 2010-11-12 2010-11-12
PCT/EP2011/065877 WO2012035028A1 (en) 2010-09-14 2011-09-13 Compositions for the vaginal and oral administration of lactobacillus and uses thereof

Publications (1)

Publication Number Publication Date
UA115520C2 true UA115520C2 (uk) 2017-11-27

Family

ID=43798526

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201302550A UA115520C2 (uk) 2010-09-14 2011-09-13 Дієтична або фармацевтична композиція на основі лактобацил для вагінального або перорального введення

Country Status (6)

Country Link
US (1) US8846027B2 (uk)
EP (2) EP2428214A1 (uk)
CA (1) CA2809398C (uk)
EA (1) EA024951B1 (uk)
UA (1) UA115520C2 (uk)
WO (1) WO2012035028A1 (uk)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2992861B1 (fr) * 2012-07-09 2014-10-17 Probionov Utilisation de thiosulfate pour potentialiser l'effet anti-pathogene des lactobacilles
FR2992973B1 (fr) * 2012-07-09 2015-12-18 S P M D Nouvelle souche de lactobacillus crispatus
FR3018193B1 (fr) * 2014-03-10 2017-09-08 Probionov Comprime vaginal muco-adhesif a liberation prolongee
WO2015173693A1 (en) * 2014-05-16 2015-11-19 Pizeta Group Srl Compositions containing boric acid and a mixture of lactobacillus
CZ2014565A3 (cs) 2014-08-22 2016-03-02 Vysoká škola chemicko - technologická v Praze Kmeny laktobacilů produkující látky účinné proti vaginálním patogenům, jejich použití a hygienické prostředky je obsahující
RU2572351C1 (ru) * 2015-03-03 2016-01-10 Вячеслав Михайлович Абрамов ШТАММ БАКТЕРИЙ Lactobacillus jensenii, ОБЛАДАЮЩИЙ ШИРОКИМ СПЕКТРОМ АНТАГОНИСТИЧЕСКОЙ АКТИВНОСТИ И ПРОБИОТИЧЕСКИЙ КОНСОРЦИУМ ЛАКТОБАКТЕРИЙ ДЛЯ ИЗГОТОВЛЕНИЯ БАКТЕРИАЛЬНЫХ ПРЕПАРАТОВ
WO2016167489A1 (ko) * 2015-04-16 2016-10-20 주식회사 고바이오랩 질 내 병원성 미생물에 대한 증식억제활성을 갖는 락토바실러스 속 균주
JP6837015B2 (ja) * 2015-06-29 2021-03-03 フェリング ベスローテン フェンノートシャップ たとえば、細菌性膣炎の治療のためのＬａｃｔｏｂａｃｉｌｌｕｓ ｒｈａｍｎｏｓｕｓ（ラクトバチルス・ラムノサス）細菌
CN104998152A (zh) * 2015-07-17 2015-10-28 青岛华仁技术孵化器有限公司 用于治疗慢性***的中药
US11260086B2 (en) 2016-07-11 2022-03-01 The Brigham And Women's Hospital, Inc. Medicinal vaginal lactobacillus cocktail
WO2018115361A1 (en) * 2016-12-21 2018-06-28 Agriculture And Food Development Authority (Teagasc) Human lactobacilli strains
GB201708932D0 (en) * 2017-06-05 2017-07-19 Probi Ab Microbial compositions
DE102017113263A1 (de) * 2017-06-16 2018-12-20 Lactopia GmbH Pharmazeutische Zusammensetzung enthaltend Bakterienstämme aus der Familie der Lactobacillaceae und Molke
EP3427745A1 (en) * 2017-07-12 2019-01-16 Nederlandse Organisatie voor toegepast- natuurwetenschappelijk onderzoek TNO New probiotic composition for prevention of bacterial vaginosis
WO2020007780A1 (en) * 2018-07-02 2020-01-09 Artpred B.V. Method and kit for altering the outcome of an assisted reproductive technology procedure
CN111088178B (zh) * 2018-10-23 2022-11-22 上海上药信谊药厂有限公司 一种产乳酸和h2o2的乳杆菌及其应用
CN110656060B (zh) * 2019-08-09 2020-08-07 四川厌氧生物科技有限责任公司 多联乳杆菌组合物及其在女性***健康中的应用
US11037655B2 (en) 2019-10-16 2021-06-15 University Of Maryland, Baltimore Microbiome-based informed method to formulate live biotherapeutics
US10967012B2 (en) 2019-10-16 2021-04-06 University Of Maryland, Baltimore Microbiome-based informed method to formulate live biotherapeutics
EP4108249A4 (en) * 2020-02-17 2024-02-07 Acebiome Inc. COMPOSITION FOR THE TREATMENT OF CLIMATE DISORDERS COMPRISING LACTOBACILLUS GASSERI BNR17
IT202000004663A1 (it) * 2020-03-05 2021-09-05 Marca Antonio La Nuovo uso di probiotici
AU2021284269A1 (en) * 2020-06-01 2023-01-05 Ferring B.V. Vaginal microbiota compositions
KR102207512B1 (ko) * 2020-06-08 2021-01-27 (주)성운파마코피아 항균 활성을 갖는 락토바실러스 젠세니 swpm104
CA3184278A1 (en) * 2020-06-16 2021-12-23 Dsm Ip Assets B.V. A composition for reducing the risk of urinary tract infection and vaginal infection in women
IT202000016666A1 (it) * 2020-07-09 2022-01-09 Uriach Italy S R L Nuovo ceppo della specie lacticaseibacillus rhamnosus, sue composizioni e loro uso nel trattamento di infezioni genitourinarie
CA3204068A1 (en) * 2021-01-05 2022-07-14 Charlotte VEDEL Strains, compositions and methods of use
CN112342175B (zh) * 2021-01-09 2021-05-04 南京北极光生物科技有限公司 一种***健康益生菌组合物及其应用
EP4294417A1 (en) * 2021-02-19 2023-12-27 Imperial College Innovations Limited Lactobacillus crispatus composition for use in pregnant subjects
CN113862188B (zh) * 2021-10-15 2023-06-16 广东一元兰欣生物科技有限公司 一株格氏乳杆菌ls03及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL143632A0 (en) 1998-12-11 2002-04-21 Urex Biotech Inc Pharmaceutical compositions containing lactobacillus
SE528382C2 (sv) * 2004-10-05 2006-10-31 Probi Ab Probiotiska lactobacillusstammar för förbättrad vaginal hälsa

Also Published As

Publication number Publication date
EP2509610B1 (en) 2013-03-27
EA024951B1 (ru) 2016-11-30
US20130171253A1 (en) 2013-07-04
EP2428214A1 (en) 2012-03-14
US8846027B2 (en) 2014-09-30
EA201390305A1 (ru) 2013-09-30
EP2509610A1 (en) 2012-10-17
WO2012035028A1 (en) 2012-03-22
CA2809398A1 (en) 2012-03-22
CA2809398C (en) 2018-04-10

Similar Documents

Publication Publication Date Title
UA115520C2 (uk) Дієтична або фармацевтична композиція на основі лактобацил для вагінального або перорального введення
GB2511993A (en) Prebiotic formulations and methods of use
EP3904502A3 (en) Compositions and methods
SG10201901259RA (en) Prebiotic formulations and methods of use
IN2012DN01638A (uk)
MX2015006491A (es) Composiciones bacterianas sinergicas y metodos de produccion y uso de las mismas.
MY148872A (en) Use of bifidobacterium longum for the prevention and treatment of inflammation
UA100551C2 (en) Synbiotic mixture
MX2019005289A (es) Composiciones de corticosteroides administradas oralmente.
MY189329A (en) Mixture of non-digestible oligosaccharides for stimulating the immune system
UA109876C2 (uk) Композиція, що містить bifidobacterium longum cncm i-2618, для лікування та профілактики імунних розладів
PH12017501688A1 (en) Intranasal benzodiazepine pharmaceutical compositions
MX2018000488A (es) Composicion de autoformacion de pelicula para el cuidado oral.
WO2012098562A3 (en) Liquid oral compositions of lanthanum salts
MY161595A (en) Oral care compositions
GB201200062D0 (en) Estradiol oromucosal liquid compositions
BR112013028709A2 (pt) cepas bacterianas capazes de metabolizar oxalatos
MX2011012071A (es) Prevencion y tratamiento de diarrea alergica.
MX2014000066A (es) Formulaciones mucoadhesivas en gel de alta dosificación de metronidazol de base acuosa y su uso para tratar la vaginosis bacteriana.
MX360411B (es) Uso de tiosulfato para potenciar el efecto anti-patogenico de los lactobacilos.
MX346332B (es) Cepas probioticas para aumentar la resistencia transepitelial.
WO2014096083A3 (fr) Utilisation de microorganismes probiotiques comme agent favorisant la synthèse de mélanine
MY170190A (en) Use of a fermented soy extract as a prebiotic composition
TN2015000156A1 (en) Dispersible tablet
BR112015032351A2 (pt) composição compreendendo l. rhamnosus gg